Stevens Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,022
| Closed | -$1.68M | – | 390 |
|
|
2024
Q3 | $1.68M | Buy |
+17,022
| New | +$1.68M | 0.24% | 55 |
|
|
2024
Q2 | – | Sell |
-24,596
| Closed | -$2.33M | – | 349 |
|
|
2024
Q1 | $2.33M | Buy |
+24,596
| New | +$2.33M | 0.45% | 44 |
|
|
2023
Q3 | – | Sell |
-12,644
| Closed | -$1.05M | – | 352 |
|
|
2023
Q2 | $1.05M | Buy |
12,644
+8,442
| +201% | +$702K | 0.22% | 96 |
|
|
2023
Q1 | $320K | Sell |
4,202
-61,798
| -94% | -$4.71M | 0.08% | 148 |
|
|
2022
Q4 | $5.48M | Sell |
66,000
-1,826
| -3% | -$152K | 3.46% | 7 |
|
|
2022
Q3 | $5.38M | Sell |
67,826
-32,474
| -32% | -$2.58M | 3.45% | 6 |
|
|
2022
Q2 | $7.45M | Buy |
100,300
+23,300
| +30% | +$1.73M | 5.18% | 6 |
|
|
2022
Q1 | $6.92M | Buy |
77,000
+41,405
| +116% | +$3.72M | 1.51% | 14 |
|
|
2021
Q4 | $3.99M | Buy |
35,595
+33,672
| +1,751% | +$3.77M | 0.92% | 26 |
|
|
2021
Q3 | $242K | Sell |
1,923
-16,677
| -90% | -$2.1M | 0.1% | 147 |
|
|
2021
Q2 | $2.52M | Sell |
18,600
-32,555
| -64% | -$4.41M | 0.74% | 21 |
|
|
2021
Q1 | $6.94M | Sell |
51,155
-48,545
| -49% | -$6.58M | 3.82% | 8 |
|
|
2020
Q4 | $14M | Buy |
99,700
+6,200
| +7% | +$873K | 6.89% | 2 |
|
|
2020
Q3 | $10.4M | Buy |
+93,500
| New | +$10.4M | 3.87% | 4 |
|